2022 Speakers

 
 
 

Galit Alter, Associate Professor Of Medicine, Harvard Medical School

Galit Alter | Associate Professor Of Medicine | Harvard Medical School » speaking at Vaccine Congress USA

Stephen Auvil, Executive Vice President – Operations & Programs, Tedco

Stephen Auvil | Executive Vice President – Operations & Programs | Tedco » speaking at Vaccine Congress USA

Lindsay Robert Baden, Associate Professor, Brigham and Women's Hospital Associate Professor of Medicine, Harvard Medical School, Brigham and Women's Hospital

Lindsay Robert Baden | Associate Professor, Brigham and Women's Hospital Associate Professor of Medicine, Harvard Medical School | Brigham and Women's Hospital » speaking at Vaccine Congress USA

Roy Baynes, Senior Vice President And Head Global Clinical Development, Chief Medical Officer, Merck Research Laboratories

Roy Baynes | Senior Vice President And Head Global Clinical Development, Chief Medical Officer | Merck Research Laboratories » speaking at Vaccine Congress USA

Jay Berzofsky, Branch Chief, Vaccine Branch, National Cancer Institute - NIH

Jay Berzofsky | Branch Chief, Vaccine Branch | National Cancer Institute - NIH » speaking at Vaccine Congress USA

Robert Chen, Scientific Director, Brighton Collaboration

Robert Chen | Scientific Director | Brighton Collaboration » speaking at Vaccine Congress USA

Roman Chicz, Associate Vice President And Global Head Of External Research And Development, Sanofi Pasteur

Roman Chicz | Associate Vice President And Global Head Of External Research And Development | Sanofi Pasteur » speaking at Vaccine Congress USA

Amy Chung, Laboratory Head, The Peter Doherty Institute For Infection and Immunity

Amy Chung | Laboratory Head | The Peter Doherty Institute For Infection and Immunity » speaking at Vaccine Congress USA

Heath Damron, Director, Vaccine Development Center, Vaccine Development Center at West Virginia University School of Medicine

Heath Damron | Director, Vaccine Development Center | Vaccine Development Center at West Virginia University School of Medicine » speaking at Vaccine Congress USA

Barry Datlof, Chief, Business Development and Commercialization, U.S. Army Medical Research and Development Command

Barry Datlof | Chief, Business Development and Commercialization | U.S. Army Medical Research and Development Command » speaking at Vaccine Congress USA

Michel de Baar, Executive Director, BD&L Europe, MSD

Michel de Baar | Executive Director, BD&L Europe | MSD » speaking at Vaccine Congress USA

Cynthia Derdeyn, Professor, Emory University

Cynthia Derdeyn | Professor | Emory University » speaking at Vaccine Congress USA

Anna Durbin, Associate Professor, Johns Hopkins Bloomberg School of Public Health

Anna Durbin | Associate Professor | Johns Hopkins Bloomberg School of Public Health » speaking at Vaccine Congress USA

Simon Eade, Global Commercial Strategy Lead Pulmonary Hypertension, Janssen

Simon Eade | Global Commercial Strategy Lead Pulmonary Hypertension | Janssen » speaking at Vaccine Congress USA

Chris Earnhart, Chief Technology Officer, JPEO-CBRND

Chris Earnhart | Chief Technology Officer | JPEO-CBRND » speaking at Vaccine Congress USA

Leonard Friedland, Vice President Of Scientific Affairs And Public Health Vaccines, GSK

Leonard Friedland | Vice President Of Scientific Affairs And Public Health Vaccines | GSK » speaking at Vaccine Congress USA

Cyril Gay, Senior National Program Leader, A.R.S. National Programs

Cyril Gay | Senior National Program Leader | A.R.S. National Programs » speaking at Vaccine Congress USA

Bruce Gellin, President Global Immunization, Sabin Vaccine Institute

Bruce Gellin | President Global Immunization | Sabin Vaccine Institute » speaking at Vaccine Congress USA

Rebecca Gentile, Associate Director, Merck

Rebecca Gentile | Associate Director | Merck » speaking at Vaccine Congress USA

Volker Gerdts, Director And Chief Executive Officer, VIDO

Volker Gerdts | Director And Chief Executive Officer | VIDO » speaking at Vaccine Congress USA

Ann Ginsberg, Deputy Director, B.M.G.F.

Ann Ginsberg | Deputy Director | B.M.G.F. » speaking at Vaccine Congress USA

Gregory Glenn, President, Research And Development, Novavax

Gregory Glenn | President, Research And Development | Novavax » speaking at Vaccine Congress USA

Tini Grauwet, Scientific director, SGS Health Science

Tini Grauwet | Scientific director | SGS Health Science » speaking at Vaccine Congress USA

Beth Ann Griswold-Coller, Executive Director, Vaccines Clinical Research,, Merck Research Laboratories

Beth Ann Griswold-Coller | Executive Director, Vaccines Clinical Research, | Merck Research Laboratories » speaking at Vaccine Congress USA

Duane Gubler, Professor Emeritus, Duke-NUS Graduate Medical School

Duane Gubler | Professor Emeritus | Duke-NUS Graduate Medical School » speaking at Vaccine Congress USA

Swati Gupta, Vice President, Research Integration And Innovation, International Aids Vaccine Initiative

Swati Gupta | Vice President, Research Integration And Innovation | International Aids Vaccine Initiative » speaking at Vaccine Congress USA

Melinda Hamer, Chief, Clinical Trials Center, Walter Reed Army Institute Of Research

Melinda Hamer | Chief, Clinical Trials Center | Walter Reed Army Institute Of Research » speaking at Vaccine Congress USA

Kathryn Hashey, US Vaccine Policy Lead, GSK

Kathryn Hashey | US Vaccine Policy Lead | GSK » speaking at Vaccine Congress USA

Jon Heinrichs, AVP, Sanofi Pasteur

Jon Heinrichs | AVP | Sanofi Pasteur » speaking at Vaccine Congress USA

Jenny Hendriks, Head Biomarkers, Janssen Vaccines & Prevention B.V.

Jenny Hendriks | Head Biomarkers | Janssen Vaccines & Prevention B.V. » speaking at Vaccine Congress USA

Stephen Hoffman, Chief Executive And Scientific Officer, Sanaria

Stephen Hoffman | Chief Executive And Scientific Officer | Sanaria » speaking at Vaccine Congress USA

Peter Hotez, Dean, National School Of Tropical Medicine, Co-Director, Texas Children's Hospital Center, Baylor College of Medicine

Peter Hotez | Dean, National School Of Tropical Medicine, Co-Director, Texas Children's Hospital Center | Baylor College of Medicine » speaking at Vaccine Congress USA

Hector Izurieta, Associate Director for Novel Clinical Investigations Office of Vaccine Research and Review (OVRR) CBER, U.S. Federal Drug Administration

Hector Izurieta | Associate Director for Novel Clinical Investigations Office of Vaccine Research and Review (OVRR) CBER | U.S. Federal Drug Administration » speaking at Vaccine Congress USA

Richard Kennedy, Professor Of Medicine, Co-Director, Mayo Vaccine Research Group, Mayo Clinic

Richard Kennedy | Professor Of Medicine, Co-Director, Mayo Vaccine Research Group | Mayo Clinic » speaking at Vaccine Congress USA

Jerome Kim, Director General, International Vaccine Institute

Jerome Kim | Director General | International Vaccine Institute » speaking at Vaccine Congress USA

Wayne Koff, President And Chief Executive Officer, The Human Vaccines Project

Wayne Koff | President And Chief Executive Officer | The Human Vaccines Project » speaking at Vaccine Congress USA

Mahesh Kumar, Senior VP, Global Biologics, Zoetis

Mahesh Kumar | Senior VP, Global Biologics | Zoetis » speaking at Vaccine Congress USA

Peter Kwong, Chief, Structural Biology Section, National Institute of Health - NIAID

Peter Kwong | Chief, Structural Biology Section | National Institute of Health - NIAID » speaking at Vaccine Congress USA

Ofer Levy, Director, Precision Vaccines Program, Boston Children's Hospital Harvard Medical School

Ofer Levy | Director, Precision Vaccines Program | Boston Children's Hospital Harvard Medical School » speaking at Vaccine Congress USA

Bengt Johansson Lindbom, CSO, MinervaX

Bengt Johansson Lindbom | CSO | MinervaX » speaking at Vaccine Congress USA

Anne Lyerly, Professor, University Of North Carolina

Anne Lyerly | Professor | University Of North Carolina » speaking at Vaccine Congress USA

Christine Guillard Maure, Project Manager, World Health Organisation

Christine Guillard Maure | Project Manager | World Health Organisation » speaking at Vaccine Congress USA

Matthew Memoli, Director, NIAID-NIH

Matthew Memoli | Director | NIAID-NIH » speaking at Vaccine Congress USA

Nelson Michael, Director, Center for Infectious Disease Research, Walter Reed Army Institute of Research

Nelson Michael | Director, Center for Infectious Disease Research | Walter Reed Army Institute of Research » speaking at Vaccine Congress USA

Pedro Moro, Epidemiologist, Centers for Disease Control and Prevention

Pedro Moro | Epidemiologist | Centers for Disease Control and Prevention » speaking at Vaccine Congress USA

Flor Munoz-Rivas, Assistant Professor Of Pediatrics-Infectious Disease, Baylor College of Medicine

Flor Munoz-Rivas | Assistant Professor Of Pediatrics-Infectious Disease | Baylor College of Medicine » speaking at Vaccine Congress USA

Shankar Musunuri, Chairman, Chief Executive Officer and Co-founder, Ocugen

Shankar Musunuri | Chairman, Chief Executive Officer and Co-founder | Ocugen » speaking at Vaccine Congress USA

Saad Omer, Director, Yale Institute for Global Health

Saad Omer | Director | Yale Institute for Global Health » speaking at Vaccine Congress USA

Inna Ovsyannikova, Professor Of Medicine, Mayo Foundation For Medical Education and Research

Inna Ovsyannikova | Professor Of Medicine | Mayo Foundation For Medical Education and Research » speaking at Vaccine Congress USA

Mikkel W. Pedersen, Chief Scientific Officer, Vaccibody As

Mikkel W. Pedersen | Chief Scientific Officer | Vaccibody As » speaking at Vaccine Congress USA

Stanley Plotkin, Emeritus Professor, University of Pennsylvania School Of Medicine

Stanley Plotkin | Emeritus Professor | University of Pennsylvania School Of Medicine » speaking at Vaccine Congress USA

Gregory Poland, Director Of Mayo Vaccine Research Group, Mayo Clinic

Gregory Poland | Director Of Mayo Vaccine Research Group | Mayo Clinic » speaking at Vaccine Congress USA

Juergen Richt, Director, Kansas State University

Juergen Richt | Director | Kansas State University » speaking at Vaccine Congress USA

Roxana Rustomjee, Senior Vice President Research and Development, Sabin Vaccine Institute

Roxana Rustomjee | Senior Vice President Research and Development | Sabin Vaccine Institute » speaking at Vaccine Congress USA

Jerry Sadoff, Senior Advisor, Janssen

Jerry Sadoff | Senior Advisor | Janssen » speaking at Vaccine Congress USA

Michael Salgaller, Supervisor, Invention Development And Marketing Unit, National Cancer Institute - NIH

Michael Salgaller | Supervisor, Invention Development And Marketing Unit | National Cancer Institute - NIH » speaking at Vaccine Congress USA

Michael Santos, Vice President, FNIH

Michael Santos | Vice President | FNIH » speaking at Vaccine Congress USA

Mark Schleiss, Department Of Pediatrics Professor, University of Minnesota

Mark Schleiss | Department Of Pediatrics Professor | University of Minnesota » speaking at Vaccine Congress USA

Hanneke Schuitemaker, Vice President And Head Of Viral Vaccine Discovery And Translational Medicine, Janssen

Hanneke Schuitemaker | Vice President And Head Of Viral Vaccine Discovery And Translational Medicine | Janssen » speaking at Vaccine Congress USA

Shite Sebastian, Vice President, Affinivax

Shite Sebastian | Vice President | Affinivax » speaking at Vaccine Congress USA

Alessandro Sette, Center Head, Division Head, And Professor,, La Jolla Institute for Allergy and Immunology

Alessandro Sette | Center Head, Division Head, And Professor, | La Jolla Institute for Allergy and Immunology » speaking at Vaccine Congress USA

Albert Shaw, Professor Of Medicine (Infectious Diseases), Yale University

Albert Shaw | Professor Of Medicine (Infectious Diseases) | Yale University » speaking at Vaccine Congress USA

Pei-Yong Shi, Kempner Professor Of Human Genetics, University of Texas Medical Branch

Pei-Yong Shi | Kempner Professor Of Human Genetics | University of Texas Medical Branch » speaking at Vaccine Congress USA

Lora Shimp, Director - Immunization Center, John Snow Inc

Lora Shimp | Director - Immunization Center | John Snow Inc » speaking at Vaccine Congress USA

William Smith, Chief Executive Officer, Alliance for Multispecialty Research LLC

William Smith | Chief Executive Officer | Alliance for Multispecialty Research LLC » speaking at Vaccine Congress USA

Daniel Stoughton, Program Officer, National Institutes of Health

Daniel Stoughton | Program Officer | National Institutes of Health » speaking at Vaccine Congress USA

Walter Straus, Vice-President, Clinical Safety Lead, Moderna Therapeutics

Walter Straus | Vice-President, Clinical Safety Lead | Moderna Therapeutics » speaking at Vaccine Congress USA

Terrence Stull, SVP Research, Phoenix Childrens Hospital

Terrence Stull | SVP Research | Phoenix Childrens Hospital » speaking at Vaccine Congress USA

Adel Talaat, Professor Of Microbiology, University of Wisconsin-Madison

Adel Talaat | Professor Of Microbiology | University of Wisconsin-Madison » speaking at Vaccine Congress USA

Sybil Tasker, CMO, Codagenix Inc.

Sybil Tasker | CMO | Codagenix Inc. » speaking at Vaccine Congress USA

Stephen Thomas, Chief, Division Of Infectious Diseases, New York Upstate Medical University

Stephen Thomas | Chief, Division Of Infectious Diseases | New York Upstate Medical University » speaking at Vaccine Congress USA

Steve Thorne, Chief Scientific Officer, Western Oncolytics

Steve Thorne | Chief Scientific Officer | Western Oncolytics » speaking at Vaccine Congress USA

Gregory Tobin, Chief Executive Officer, Biological Mimetics, Inc.

Gregory Tobin | Chief Executive Officer | Biological Mimetics, Inc. » speaking at Vaccine Congress USA

Koen Torfs, VP Global Reimbursement & Real World Evidence, Janssen

Kumaran Vadivelu, Vice President, Vaccine Development Team Leader, GSK

Kumaran Vadivelu | Vice President, Vaccine Development Team Leader | GSK » speaking at Vaccine Congress USA

David Weiner, VP, Director of Vaccine & Immunology Center, The Wistar Institute

David Weiner | VP, Director of Vaccine & Immunology Center | The Wistar Institute » speaking at Vaccine Congress USA

Daniel Wolfe, Project Officer, Biomedical Advanced Research And Development Authority

Daniel Wolfe | Project Officer | Biomedical Advanced Research And Development Authority » speaking at Vaccine Congress USA

Larry Wolfraim, Program Officer, Biodefense Vaccines & Other Biolgl Product Dvpmt Sect (HNM5C2)

Larry Wolfraim | Program Officer | Biodefense Vaccines & Other Biolgl Product Dvpmt Sect (HNM5C2) » speaking at Vaccine Congress USA